AU4611496A - Elcatonin controlled release microsphere formulation for treatment of osteoporosis - Google Patents

Elcatonin controlled release microsphere formulation for treatment of osteoporosis

Info

Publication number
AU4611496A
AU4611496A AU46114/96A AU4611496A AU4611496A AU 4611496 A AU4611496 A AU 4611496A AU 46114/96 A AU46114/96 A AU 46114/96A AU 4611496 A AU4611496 A AU 4611496A AU 4611496 A AU4611496 A AU 4611496A
Authority
AU
Australia
Prior art keywords
elcatonin
osteoporosis
treatment
controlled release
release microsphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46114/96A
Inventor
Henry Baxter Abajian
Douglas R Flanagan
John Fowler Noble
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innapharma Inc
Original Assignee
Innapharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innapharma Inc filed Critical Innapharma Inc
Publication of AU4611496A publication Critical patent/AU4611496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU46114/96A 1995-02-28 1995-12-29 Elcatonin controlled release microsphere formulation for treatment of osteoporosis Abandoned AU4611496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US395044 1989-08-17
US39504495A 1995-02-28 1995-02-28
PCT/US1995/017059 WO1996026716A1 (en) 1995-02-28 1995-12-29 Elcatonin controlled release microsphere formulation for treatment of osteoporosis

Publications (1)

Publication Number Publication Date
AU4611496A true AU4611496A (en) 1996-09-18

Family

ID=23561479

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46114/96A Abandoned AU4611496A (en) 1995-02-28 1995-12-29 Elcatonin controlled release microsphere formulation for treatment of osteoporosis

Country Status (3)

Country Link
JP (1) JPH11501027A (en)
AU (1) AU4611496A (en)
WO (1) WO1996026716A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2541908T3 (en) * 2001-10-10 2015-07-28 Pierre Fabre Medicament Biodegradable extended-release microspheres and their preparation procedure
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
CN102600430B (en) * 2012-03-31 2013-05-01 沈庆坡 Medicine for curing femoral head necrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US5175146A (en) * 1989-12-05 1992-12-29 Vical, Inc. Synthetic calcitonin peptides

Also Published As

Publication number Publication date
WO1996026716A1 (en) 1996-09-06
JPH11501027A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
AU9469198A (en) New improved formulation for treatment of osteoporosis
AU5675598A (en) Time-specific controlled release dosage formulations and method of preparing same
AU6359898A (en) Apparatus for controlled thermal treatment of tissue
AU6196394A (en) Controlled release formulation
AU5471996A (en) Process for the preparation of microcapsule compositions
AUPN504095A0 (en) Cement formulation
AU6824996A (en) Controlled release products
AU9119798A (en) An apparatus for preventing loss of a composition during a medical procedure
AU6659196A (en) Paroxetine controlled release compositions
AU1677999A (en) Process for the preparation of magnesium and carbonate substituted hydroxyapatite
AU5545996A (en) Process for the preparation of triazolones
AU1036697A (en) Surgical anchorage
HUP0003840A3 (en) Controlled released medical formulation
AU6253094A (en) Methods for the treatment of osteoporosis
AU8758298A (en) Process for the preparation of 2'-fluoro-5-methyl-beta -l-arabinofuranosyluridine
AU8869398A (en) Medical apparatus for relief of pain
AU6648194A (en) Systems for controlled release of pilocarpine
AU3782397A (en) Slow release formulations of pesticides
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU3861397A (en) Controlled release tablet formulation of isosorbide-5-mononitrate
AU4611496A (en) Elcatonin controlled release microsphere formulation for treatment of osteoporosis
AU1979499A (en) Apparatus for therapeutic electromagnetic treatment
AU1786799A (en) Composition for the controlled release of active compounds
AU5486396A (en) Process for the preparation of spiroindolines